Home | University of Cape Town

H3D SMAB

H3D's Scientific and Management Advisory Board (SMAB) help strategically guide and implement H3D’s scientific programmes

Launch of the J&J Satellite Center at H3D

Launch of the J&J Center for Global Health Discovery at H3D

The Satellite Center at H3D, the only one in Africa, was launched in Cape Town on 25 April 2022. The partnership will ensure that any preclinical drug candidates will align with South African public health needs and boost H3D’s AMR efforts.

Kelly Chibale named as one of the top voices in Public Health

Kelly Chibale was recently named as one of the top 25 voices in African Public Health

UCT funding to support cost-effective manufacturing of pharmaceuticals in South Africa

The manufacturing and availability of medicines in sub-Saharan Africa will receive a major boost with the injection of R13 million to the University of Cape Town’s (UCT) Holistic Drug Discovery and Development Centre (H3D).

In the Spotlight: Ending TB in Africa

This week H3D Centre’s Dr. Nashied Peton, Investigator, TB Biology, shares his take on the factors contributing to Africa’s high TB burden, and offers insights into what can be done to lower its prevalence on the continent.

Group of researchers at University of Venda

University of Cape Town's H3D Centre and University of Venda Receive R2.4 million Grant to Boost TB Research

The University of Cape Town’s (UCT) Holistic Drug Discovery and Development (H3D) Centre and the University of Venda (UNIVEN) have jointly been awarded a R2.4 million grant to boost local tuberculosis (TB) research in South Africa.